Screener
Recursion Pharmaceuticals, Inc. RXRX Operating Lease Liability, Current
Operating Lease Liability, Current at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The source filing: Recursion Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001601830-26-000098
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Accounts payable | $12,672 | $18,118 |
| Accrued expenses and other liabilities | 56,936 | 70,230 |
| Unearned revenue | 27,586 | 37,605 |
| Operating lease liabilities | 13,249 | 12,663 |
| Notes payable and financing lease liabilities | 9,443 | 9,091 |
| Total current liabilities | 119,886 | 147,707 |
| Unearned revenue, non-current | 112,818 | 114,012 |
| Operating lease liabilities, non-current | 39,193 | 46,647 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Recursion Pharmaceuticals, Inc.'s operating lease liability, current?
- Recursion Pharmaceuticals, Inc. (RXRX) reported operating lease liability, current of $13.25M in Q2 2026.
- How has Recursion Pharmaceuticals, Inc.'s operating lease liability, current changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s operating lease liability, current increased by 12.9% year-over-year, from $11.73M to $13.25M.
- What does operating lease liability, current mean?
- Operating Lease Liability, Current as reported by Recursion Pharmaceuticals, Inc. Class A Common Stock.
Ask your AI about Recursion Pharmaceuticals, Inc.'s operating lease liability, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude